1 results match your criteria: "Nanyang Municipal Second People's Hospital[Affiliation]"
[Clinical Effects of Different Chemotherapeutic Regimens on the Patients with Multiple Myeloma].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
April 2017
Department of Hematology & Oncology, Nanyang Municipal Second People's Hospital, Nanyang 473000, Henan Province, China. E-mail:
Objective: To explore the clinical effects of T-VD regimen (bortezomib+dexamethasone+thalidomid) and T-VAD regimen (vincristine+adriamycin+dexamethasone+thalidomide) on the patients with multiple myeloma(MM).
Methods: Thirty cases of MM treated by T-VD(T-VD group) and 30 cases of MM treated by T-VAD(T-VAD group) from April 2010 to April 2012 were included in this study. The clinical effects and long-term survival were compared betwwen these 2 groups.